Patents by Inventor Oliver Wessely

Oliver Wessely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENERATING HUMAN PODOCYTE CELLS
    Publication number: 20210079357
    Abstract: Provided herein are compositions, systems, kits, and methods for generating human podocyte cells by contacting human nephron progenitor cells with an FGFR pathway inhibitor, a BMP pathway inhibitor, and a WNT pathway inhibitor. In certain embodiments, the nephron progenitor cells are further contacted with at least one factor selected from: BMP4, BMP7, lysophosphatidic acid, and gamma-secretase inhibitor XX. In certain embodiments, the contacting the nephron progenitor cells is performed under serum-free conditions.
    Type: Application
    Filed: September 4, 2020
    Publication date: March 18, 2021
    Inventors: Oliver Wessely, Uyen Wessely, Jan Jensen, Michael Bukys
  • Process for preparing and cultivating hematopoietic progenitor cells
    Patent number: 5905041
    Abstract: Process for the in vitro production of non-immortalised haematopoietic progenitor cells of the erythroid lineage, in which a population of erythroid progenitor cells is exposed to a combination of growth factors containing a glucocorticoid and an oestrogen and at least one ligand of a tyrosine kinase receptor at least until the cells begin to renew themselves.
    Type: Grant
    Filed: April 29, 1996
    Date of Patent: May 18, 1999
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Hartmut Beug, Oliver Wessely, Peter Steinlein, Eva Deiner, Maartje Marie von Lindern